Skip to main content

Table 2 Associations of ChP volume, hippocampal volume, LVV, ECT alone, and combined ChP and hippocampal volumes with the neuropsychological tests in patients in the AD continuum at baseline

From: Choroid plexus volume as a novel candidate neuroimaging marker of the Alzheimer’s continuum

Imaging markers

Outcomes

β value*

95% CI

t value

P value

Outcomes

β value*

95% CI

t value

P value

Model 1: only included one neuroimaging measure

       

ChP alone

MMSE score

-0.32

-5.25 × 10− 3 to -2.99 × 10− 3

-7.15

< 0.001

NPI score

0.23

3.28 × 10− 3 to 8.84 × 10− 3

4.51

< 0.001

HIP alone

 

0.45

2.02 × 10− 3 to 3.01 × 10− 3

10.02

< 0.001

 

-0.19

-3.56 × 10− 3 to -1.10 × 10− 3

-3.73

< 0.001

LVV alone

 

-0.52

-2.51 × 10− 4 to -1.81 × 10− 4

-12.05

< 0.001

 

0.32

1.97 × 10− 4 to 3.75 × 10− 4

6.34

< 0.001

ECT alone

 

0.46

6.29 to 8.89

11.48

< 0.001

 

-0.24

-11.60 to -5.05

-4.99

< 0.001

ChP alone

MoCA score

-0.34

-5.31 × 10− 3 to -3.15 × 10− 3

-7.70

< 0.001

ADL score

0.31

4.08 × 10− 3 to 7.58 × 10− 3

6.53

< 0.001

HIP alone

 

0.47

2.16 × 10− 3 to 3.09 × 10− 3

11.09

< 0.001

 

-0.40

-4.08 × 10− 3 to -2.52 × 10− 3

-8.32

< 0.001

LVV alone

 

-0.52

-2.43 × 10− 4 to -1.76 × 10− 4

-12.23

< 0.001

 

0.58

2.99 × 10− 4 to 4.05 × 10− 4

13.03

< 0.001

ECT alone

 

0.45

6.13 to 8.62

11.67

< 0.001

 

-0.44

-12.90 to -8.83

-10.5

< 0.001

Model 2: both of ChP and hippocampal volume together

       

ChP

MMSE score

-0.23

-4.05 × 10− 3 to -1.88 × 10− 3

-5.38

< 0.001

NPI score

0.19

2.49 × 10− 3 to 7.98 × 10− 3

3.75

< 0.001

HIP

 

0.39

1.70 × 10− 3 to 2.68 × 10− 3

8.73

< 0.001

 

-0.15

-3.01 × 10− 3 to -5.17 × 10− 4

-2.78

0.006

ChP

MoCA score

-0.24

-4.04 × 10− 3 to -2.01 × 10− 3

-5.84

< 0.001

ADL score

0.23

2.63 × 10− 3 to 6.07 × 10− 3

4.96

< 0.001

HIP

 

0.41

1.83 × 10− 3 to 2.76 × 10− 3

9.73

< 0.001

 

-0.34

-3.61 × 10− 3 to -2.04 × 10− 3

-7.09

< 0.001

Model 3: both of ChP, HIP, and CHP*HIP together

       

ChP

MMSE score

-0.25

-0.01 to 0.01

-1.26

0.208

NPI score

0.15

-0.01 to 0.02

0.66

0.508

HIP

 

0.38

4.98 × 10− 4 to 3.76 × 10− 3

2.57

0.011

 

-0.17

-6.22 × 10− 3 to 2.02 × 10− 3

-1.00

0.318

ChP*HIP

 

0.02

6.39 × 10− 7 to 6.92 × 10− 7

0.08

0.002

 

0.04

1.54 × 10− 6 to 1.82 × 10− 6

0.17

0.867

ChP

MoCA score

0.12

-6.07 × 10− 3 to 3.16 × 10− 3

0.62

0.536

ADL score

0.31

-0.01 to 0.14

1.45

0.147

HIP

 

0.51

1.27 × 10− 3 to 4.33 × 10− 3

3.60

< 0.001

 

-0.28

-4.95 × 10− 3 to 2.24 × 10− 4

1.79

0.073

ChP*HIP

 

-0.15

8.41 × 10− 7 to 4.06 × 10− 7

0.69

0.493

 

-0.09

-1.25 × 10− 6 to 8.57 × 10− 7

-0.37

0.713

  1. N = 497, adjusting for age, sex, years of education, APOE ε4 status, and eTIV. Abbreviations: AD, Alzheimer’s disease; MMSE, Mini-Mental State Examination; MoCA, Montreal Cognitive Assessment; NPI, Neuropsychiatric Inventory; ADL, Activities of Daily Living; ChP, choroid plexus volume; HIP, hippocampal volume; LVV, lateral ventricular volume; ECT, entorhinal cortical thickness; eTIV, estimated total intracranial volume